Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.46B 1.28B 1.18B 1.09B 2.07B 139B 2.1B 14.09B 5.53B 68.68B 5.49B 5.37B 236B P/E 2026 *
28.9x
P/E 2027 * 15.7x
Enterprise Value 2.8B 2.45B 2.26B 2.09B 3.96B 267B 4.03B 26.99B 10.6B 132B 10.51B 10.28B 452B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.52x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.18%
1 week+4.10%
Current month+4.62%
1 month+7.31%
3 months+89.80%
6 months+38.37%
Current year+51.29%
1 week 17.01
Extreme 17.01
18.86
1 month 17.01
Extreme 17.01
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 2026-04-30
Director of Finance/CFO 54 2023-06-27
Chief Tech/Sci/R&D Officer - 2026-02-16
Director TitleAgeSince
Chairman 64 2012-01-02
Director/Board Member 81 1991-12-31
Director/Board Member 65 2005-12-31
Date Insider Type Main position Quantity % Market Cap.
07-02Tax

Chief Financial Officer

-5,226 0.0067%
06-30Tax

Controller/Auditor

-937 0.0012%
06-30Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%+4.10%+49.25%-54.50% 1.46B
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.73%-0.52%+9.24%-5.90% 53.47B
Weighted average by Cap. +0.51%-0.92%-5.44%+0.86%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.35B 1.25B 2.37B 160B 2.41B 16.16B 6.34B 78.75B 6.29B 6.16B 271B 1.73B 1.51B 1.4B 1.29B 2.45B 165B 2.49B 16.68B 6.55B 81.29B 6.5B 6.35B 279B
Net income 42.73M 37.38M 34.48M 31.84M 60.42M 4.08B 61.44M 412M 162M 2.01B 160M 157M 6.9B 74.56M 65.22M 60.16M 55.56M 105M 7.11B 107M 719M 282M 3.5B 280M 274M 12.04B
Net Debt 1.34B 1.17B 1.08B 997M 1.89B 128B 1.92B 12.9B 5.07B 62.88B 5.03B 4.92B 216B 1.18B 1.03B 949M 876M 1.66B 112B 1.69B 11.34B 4.45B 55.25B 4.42B 4.32B 190B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
26-07-10 US$18.79 +2.18% 951,869
26-07-09 US$18.39 +6.30% 939,773
26-07-08 US$17.30 -0.92% 702,386
26-07-07 US$17.46 -3.96% 1,106,193
26-07-06 US$18.18 +0.72% 882,014
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.79USD
Average target price
18.00USD
Spread / Average Target
-4.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock